LYBALVI
Live / Registered — Registered (as of 20 Jul 2021)
What this means for you
Registered since 20 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87700839
- Registration number
- 6428572
- Mark type
- Stylized text
- Filed
- 29 Nov 2017
- Published for opposition
- 24 Apr 2018
- Registered
- 20 Jul 2021
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia
Owner
- Alkermes Pharma Ireland Limited, Dublin, IE
- Alkermes Pharma Ireland Limited, Dublin, IE
- Alkermes Pharma Ireland Limited, Dublin, IE
Prosecution history
- 20 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 17 Jun 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Jun 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 May 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 May 2021 — NON-FINAL ACTION E-MAILED
- 17 May 2021 — SU - NON-FINAL ACTION - WRITTEN
- 26 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Apr 2021 — USE AMENDMENT FILED
- 22 Apr 2021 — TEAS STATEMENT OF USE RECEIVED
- 10 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Nov 2020 — SOU EXTENSION 5 GRANTED
- 29 Oct 2020 — SOU EXTENSION 5 FILED
- 09 Nov 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Oct 2020 — SOU TEAS EXTENSION RECEIVED
- 09 May 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED